AGO2 and melanoma: Additionally, two mutant NRAS-driven melanoma cell lines (Mel-Juso; NRASQ61L/WT, and SK-MEL-2; NRASQ61H/Q61H) (34, 44) demonstrated marked growth reduction following loss of AGO2 (Fig. 4B; Figure S3, Supplementary Material).